0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi
Neofosto-465x364

Potentially life-saving treatment is safe to use for babies with neonatal sepsis, study reveals

Results from a clinical trial completed in Kenya have determined that a safe dose of the antibiotic, fosfomycin, can be used to treat babies with neonatal sepsis. This is a significant development, as there are very few antibiotics specifically licensed to treat multidrug-resistant infections in babies. The NeoFosfo trial investigated the pharmacokinetics (PK) and safety […]
Read More
LINDaMAMA-465x364

Examining the implementation of the Linda Mama free maternity program in Kenya

Maternal mortality is still unacceptably high in Kenya. A recently published policy brief examines the implementation of the Linda Mama free maternity program in Kenya. The process evaluation of the Linda Mama program reveals that there are barriers in access to maternal care, inefficiencies in the funding flow, claims process and reimbursement processes, and gaps […]
Read More
DSC_9218-465x364

Rapid Review of Interventions to Save Newborn Lives (RISE)

Mainga Hamaluba, Head of Clinical Research at the KEMRI-Wellcome Trust Research Programme in Kenya, will develop a pragmatic adaptive trial platform to evaluate key interventions for improving child survival in East Africa in real-life routine practice conditions as a faster and lower-cost alternative to traditional randomized controlled trials. Dr. Hamaluba has led a wide-range of […]
Read More

SERVE-Kenya Study

Title: Social, Ethical and Regulatory implications of conducting a malaria Vaccine Efficacy trial in a human infection study in Kenya. Duration: 46 months Background Malaria remains an important public health problem in many LMICs, including Kenya – necessitating alternative prevention and control strategies. Malaria human infection studies (HIS) – trials that involve the deliberate infection […]
Read More
Harvard_RethinkingMalaria_Sept28-29_2DayWebinar-465x364

Rethinking Malaria in the Context of COVID–19

Please join KEMRI-Wellcome and Harvard University for a special 2-day webinar on focused on thematic topics stemming from the “Rethinking Malaria in the Context of COVID–19” global engagement—Malaria Governance, Integrated Service Delivery, Training & Capacity Building for Malaria on September 28–29, 2021 from 9AM–11:30AM EDT | 4PM–6:30PM EAT. In keeping with a longstanding academic tradition, and in partnership with a committed network of co-sponsors, we have assembled a diverse group […]
Read More
Warimwe

Royal Society Africa Prize winner 2021 – Prof. George Warimwe

Congratulations to Professor George Warimwe on being awarded the Royal Society Africa Prize winner 2021! Prof. Warimwe was  awarded for his work on zoonoses vaccine development, capacity building in Africa, and his innovative research proposal. The Royal Society Africa Prize is to recognize research scientists based in Africa who are making an innovative contribution to […]
Read More
Sequencing-team-465x364

Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya.

Results from the first major genomic epidemiology of SARS-CoV-2 infections in Kenya were published today in the esteemed Nature Communications (DOI:10.1038/s41467-021-25137-x) peer-reviewed journal. The work carried by a team of scientist at the KEMRI-Wellcome Trust Research Programme and the Ministry of Health, examined cases during the early phase of the epidemic (March – July 2020). Out of […]
Read More
CIN-Logo-high-res-e1628670587831-465x364

How the partnership between KPA and KEMRI-Wellcome birthed the Clinical Information Network

They say two things change the world: people with enough fortitude, conviction and ability; and ideas of how the world can be. The same can be said of the Clinical Information Network, which was established by a small group of people with an unwavering commitment to improving child health in the country. We spoke to […]
Read More
ndungu

What it takes to reach ZERO MALARIA

By Keziah Njoki Malaria immunologist, Francis Ndungu, grew up in central Kenya where malaria is not prevalent but is now interested in understanding of how semi-immune individuals control malaria parasite growth and the associated inflammation (symptoms). He is also interested in the potential translation of that knowledge in the development of effective malaria vaccines. His […]
Read More